We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline Plc will pay $541,000 to Ohio's Medicaid program as part of a settlement resolving allegations the company inflated the average wholesale price paid by government health plans for certain prescription drugs.
Generex Biotechnology Corporation, the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced the introduction and launch of its new over-the-counter Glucose RapidSpray product in the US at the American Association of Diabetes Educators 33rd Annual Meeting & Exhibition in Los Angeles.
Shire said that it has settled pending litigation over Barr
Pharmaceuticals Inc's generic copy of the extended-release version of Shire's attention deficit hyperactivity disorder drug Adderall.
Bristol-Myers Squibb Co. and Sanofi-Aventis SA said Monday they filed an injunction against Apotex Corp. to stop the Canadian drug maker from selling a less expensive, generic version of the blood thinner Plavix and force it to recall product already sold.
ZymoGenetics, Inc. announced that it has filed a lawsuit against Bristol-Myers Squibb for infringement of its patents related to fusion protein technology.
The FDA has warned a company that makes and markets portable "oxygen enriched" air for the treatment of a variety of ailments that it is selling a drug without an approved new drug
application.
New York law firm Fitzpatrick, Cella, Harper announced that it has filed patent lawsuits on behalf of four clients defending three drug patents -- Sankyo for its hypertension drug Benicar, Eisai for its Alzheimer's disease drug Aricept and Wyeth and Altana for their heartburn drug Protonix.
Teva said Aug. 14 it has launched its generic version of Pfizer's blockbuster antidepressant Zoloft in the U.S. after a two-week delay caused by late-stage production issues.